← SOROS FUND MANAGEMENT LLC
Backtest
SOROS FUND MANAGEMENT LLC
What you'd have made by mirroring SOROS FUND MANAGEMENT LLC's public 13F filings, starting with $10,000 on Aug 14, 2024 and rebalancing at every disclosure through May 18, 2026.
8 filings replayed514 of 665 CUSIPs mapped to tickers494 closed trades250 still open
Equity curve
$10,000 mirrored · vs SPYMirror portfolio$10k in SPY
Mirror — final
$12.83K
SPY — final
$13.59K
Mirror return
+28.3%
Alpha vs SPY
-7.6%
Realized P&L · closed trades
Cumulative profit from positions opened and later soldRealized P&L
+$340.11M
Closed trades
494
Win rate
35%
Avg return / closed
+4.9%
Biggest closed trades
| Issuer | Entry | Exit | Held | Return | P&L |
|---|---|---|---|---|---|
SANDISK CORP SNDK | Q3 2025 | Q4 2025 | 1Q | +444% | +$106.19M |
ALIBABA GROUP HLDG LTD BABA | Q3 2024 | Q2 2025 | 3Q | +56% | +$41.26M |
BROWN & BROWN INC BRO | Q3 2025 | Q1 2026 | 2Q | -28% | −$31.07M |
WESTERN DIGITAL CORP WDC | Q2 2025 | Q4 2025 | 2Q | +217% | +$30.74M |
ECHOSTAR CORP SATS | Q3 2024 | Q1 2025 | 2Q | +68% | +$29.6M |
SPDR S&P 500 ETF TR SPY | Q3 2024 | Q4 2024 | 1Q | +9% | +$22.34M |
INSMED INC INSM | Q3 2024 | Q3 2025 | 4Q | +71% | +$22.27M |
ANALOG DEVICES INC ADI | Q2 2025 | Q2 2026 | 4Q | +84% | +$17.95M |
SAREPTA THERAPEUTICS INC SRPT | Q4 2024 | Q2 2025 | 2Q | -68% | −$17.46M |
AURORA INNOVATION INC AUR | Q3 2024 | Q3 2025 | 4Q | +94% | +$17.39M |
Every trade · entry date × return
Bubble = position size at entryPositiveNegativeStill open (marked to market)
Best closed pick
SNDK +444%
Worst closed pick
BIOA -75%
Total trades
744
Open trades
250